
Vaccines


Individualized follow-up of COVID-19 vaccine for some HIV patients

Dídac Macià (ISGlobal): «You have to be open to finding things you were not looking for»

Evaluating COVID-19 vaccine efficacy and its acceptance

Adelaida Sarukhan (ISGlobal): “To overcome the pandemic we need a global strategy”

Mathematics and statistics: numbers against the COVID-19

ISGlobal joins Verificat, I.Media and Aleteia to combat misinformation about COVID vaccines

Elena Martín (DCEXS-UPF): “We have verified that the mRNA of the Covid-19 vaccines would remain stable in a 3h-long journey by road”

Immunity anniversary: antibodies against SARS-CoV-2 remain one year after infection

Identified a specific region of SARS-CoV-2 useful for the diagnosis of COVID-19 and vaccine development

Down Syndrome, a high risk factor for COVID-19
